<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Berset AE</submitter><funding>NCATS NIH HHS</funding><pagination>914-921</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11111590</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(6)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To determine the effectiveness of text/telephone outreach messages and personal contact attempts on well-child care (WCC) scheduling and completion and measles, mumps, and rubella (MMR) vaccine receipt.&lt;h4>Methods&lt;/h4>We conducted an intent-to-treat, 2 × 2 factorial randomized clinical trial with 3 replications at 3 academic pediatric primary care practices from September 27, 2020 to August 6, 2021. We randomized participants to 1 of 4 groups: 1 automated message (group 1), 2 automated messages (group 2), 1 automated message plus personal contact attempts (group 3), or 2 automated messages plus personal contact attempts (group 4). Outcomes included: 1) scheduled WCC within 2 weeks (secondary outcome), 2) completed WCC within 8 weeks (secondary outcome), 3) receipt of firs</pubmed_abstract><journal>Academic pediatrics</journal><pubmed_title>Effect of Automated and Personalized Outreach Messages on Well-Child Visit Catch Up: A Randomized Clinical Trial.</pubmed_title><pmcid>PMC11111590</pmcid><funding_grant_id>UL1 TR001425</funding_grant_id><pubmed_authors>Berset AE</pubmed_authors><pubmed_authors>Brinkman WB</pubmed_authors><pubmed_authors>Burkhardt MC</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors><pubmed_authors>Mescher A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of Automated and Personalized Outreach Messages on Well-Child Visit Catch Up: A Randomized Clinical Trial.</name><description>&lt;h4>Objective&lt;/h4>To determine the effectiveness of text/telephone outreach messages and personal contact attempts on well-child care (WCC) scheduling and completion and measles, mumps, and rubella (MMR) vaccine receipt.&lt;h4>Methods&lt;/h4>We conducted an intent-to-treat, 2 × 2 factorial randomized clinical trial with 3 replications at 3 academic pediatric primary care practices from September 27, 2020 to August 6, 2021. We randomized participants to 1 of 4 groups: 1 automated message (group 1), 2 automated messages (group 2), 1 automated message plus personal contact attempts (group 3), or 2 automated messages plus personal contact attempts (group 4). Outcomes included: 1) scheduled WCC within 2 weeks (secondary outcome), 2) completed WCC within 8 weeks (secondary outcome), 3) receipt of firs</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-03-17T15:31:50.723Z</modification><creation>2025-08-16T03:07:09.023Z</creation></dates><accession>S-EPMC11111590</accession><cross_references><pubmed>38007156</pubmed><doi>10.1016/j.acap.2023.11.017</doi></cross_references></HashMap>